Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

IRF5 gene

The IRF5 gene encodes interferon regulatory factor 5. Genetic variations are associated with inflammatory bowel disease and susceptibility to systemic lupus erythematosus.

Genetests:

Clinic Method Carrier testing
Turnaround 5 days
Specimen type genomic DNA
Clinic Method Massive parallel sequencing
Turnaround 25 days
Specimen type genomic DNA
Research Method Genomic sequencing of the entire coding region
Turnaround 25 days
Specimen type genomic DNA

Related Diseases:

inflammatory_bowel_disease_14
IRF5
Susceptibility to systemic lupus erythematosus 10
IRF5

References:

1.

Akilesh HM et al. (2019) Chronic TLR7 and TLR9 signaling drives anemia via differentiation of specialized hemophagocytes.

external link
2.

Taniguchi T et al. (2001) IRF family of transcription factors as regulators of host defense.

external link
3.

Barnes BJ et al. (2001) Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes.

external link
4.

Barnes BJ et al. (2002) Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes.

external link
5.

Morley M et al. (2004) Genetic analysis of genome-wide variation in human gene expression.

external link
6.

Sigurdsson S et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus.

external link
7.

Takaoka A et al. (2005) Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.

external link
8.

Graham RR et al. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.

external link
9.

Cunninghame Graham DS et al. (2007) Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation.

external link
10.

Yanai H et al. (2007) Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression.

external link
11.

Kozyrev SV et al. (2007) Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.

external link
12.

Reddy MV et al. (2007) Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans.

external link
13.

Sigurdsson S et. al. (2007) Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis.

external link
14.

Dideberg V et al. (2007) An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.

external link
15.

Sigurdsson S et al. (2008) Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.

external link
16.

Couzinet A et al. (2008) A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis.

external link
Update: Nov. 3, 2022
Copyright © 2005-2024 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits